MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00467-015-3109-3

Медицинская библиотека · Pediatric nephrology (Berlin, Germany) · 2015

Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible.

Klaassen Ilka, Özgören Bünyamin, Sadowski Carolin E, Möller Kristina, van Husen Michael, Lehnhardt Anja, Timmermann Kirsten, Freudenberg Folke, Helmchen Udo, Oh Jun, Kemper Markus J

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Steroid-resistant nephrotic syndrome (SRNS) is still regarded as a serious disease although treatment with cyclosporine (CSA) has improved outcome. However, the duration of treatment in responders is unclear, and treatment of patients with genetic causes is a matter of debate.

METHODS

Thirty-six patients with SRNS were studied retrospectively. Median age at presentation was 3.2 (range, 0.06-15.0) and median follow-up 15.5 years (range, 1.8-27.7), respectively; 23 (64%) had focal segmental glomerulosclerosis (FSGS) on biopsy. In 33/36 patients (92%), genetic testing was performed for at least three most common genes known to be mutated in SRNS.

RESULTS

Nineteen patients (53%), especially those with minimal change nephrotic syndrome (MCNS) at initial biopsy (p < 0.002), entered complete remission with CSA monotherapy, including one patient with compound heterozygous NPHS1 and dominant ACTN4 mutation, respectively. Ten patients entered partial remission (28%, all FSGS), including two with NPHS2 mutations. Seven patients (six FSGS, one MCNS) did not respond to treatment. In 15 of 19 responders to CSA, treatment was stopped after a median of 3.1 years (range, 0.5-14) and no further relapses occurred in 11/15 (73%) patients with median follow-up of 9.7 years.

CONCLUSIONS

CSA monotherapy is effective in SRNS. Discontinuation of CSA is possible in many patients with complete remission.

Для цитирования: Klaassen Ilka, Özgören Bünyamin, Sadowski Carolin E, Möller Kristina, van Husen Michael, Lehnhardt Anja, Timmermann Kirsten, Freudenberg Folke, Helmchen Udo, Oh Jun, Kemper Markus J. Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible.. Pediatric nephrology (Berlin, Germany). 2015. DOI: 10.1007/s00467-015-3109-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.